Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Williams

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Trends in Cancer|January 8, 2026
Targeting persister cells: proactively overcoming therapy resistance in aggressive B cell lymphomasJianguo Tao, Kevin Qiu, Michael E Williams
Clinical Advances in Hematology & Oncology : H&O|June 12, 2010
Clinical roundtable monograph: Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussionMyron S Czuczman, John P Leonard, Michael E Williams
Current Oncology Reports|July 16, 2021
Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and ManagementKrista M Isaac, Craig A Portell, Michael E Williams
Seminars in Respiratory and Critical Care Medicine|June 23, 2006
Hematologic disorders in critically ill patientsKelly W Mercer, B Gail Macik, Michael E Williams
Clinical Advances in Hematology & Oncology : H&O|June 18, 2010
Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussionMyron S Czuczman, John P Leonard, Michael E Williams
Expert Opinion on Pharmacotherapy|April 15, 2009
Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphomaMark Prichard, Thomas Harris, Michael E Williams, et al.
Clinical Lymphoma|April 24, 2002
Testicular lymphoma: a literature review and report of a case with a zoster-like cutaneous recurrenceRichard M Ingram, Michael E Williams, William A Fintel, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2010
Management of mantle cell lymphoma: key challenges and next stepsMichael E Williams, Martin Dreyling, Jane Winter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
The shaving reaction: rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytesPaul V Beum, Adam D Kennedy, Michael E Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2017
Implementation of a Model-Based Design in a Phase Ib Study of Combined Targeted AgentsNolan A Wages, Craig A Portell, Michael E Williams, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Trends in Cancer|January 8, 2026
Targeting persister cells: proactively overcoming therapy resistance in aggressive B cell lymphomasJianguo Tao, Kevin Qiu, Michael E Williams
Clinical Advances in Hematology & Oncology : H&O|June 12, 2010
Clinical roundtable monograph: Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussionMyron S Czuczman, John P Leonard, Michael E Williams
Current Oncology Reports|July 16, 2021
Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and ManagementKrista M Isaac, Craig A Portell, Michael E Williams
Seminars in Respiratory and Critical Care Medicine|June 23, 2006
Hematologic disorders in critically ill patientsKelly W Mercer, B Gail Macik, Michael E Williams
Clinical Advances in Hematology & Oncology : H&O|June 18, 2010
Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussionMyron S Czuczman, John P Leonard, Michael E Williams
Expert Opinion on Pharmacotherapy|April 15, 2009
Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphomaMark Prichard, Thomas Harris, Michael E Williams, et al.
Clinical Lymphoma|April 24, 2002
Testicular lymphoma: a literature review and report of a case with a zoster-like cutaneous recurrenceRichard M Ingram, Michael E Williams, William A Fintel, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 30, 2010
Management of mantle cell lymphoma: key challenges and next stepsMichael E Williams, Martin Dreyling, Jane Winter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
The shaving reaction: rituximab/CD20 complexes are removed from mantle cell lymphoma and chronic lymphocytic leukemia cells by THP-1 monocytesPaul V Beum, Adam D Kennedy, Michael E Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2017
Implementation of a Model-Based Design in a Phase Ib Study of Combined Targeted AgentsNolan A Wages, Craig A Portell, Michael E Williams, et al.
Pageof 6